Dyne Therapeutics Inactive 10-K2017 FY Annual report

Filed: 22 Feb 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: abeyance, Acknowledgment, AES, Annex, ANP, artificially, auxiliary, BNSF, broke, Bruce, Bulletin, burden, burn, Calumet, certify, CFR, Club, comment, compel, contrast, deal, DEOK, disaggregated, discourage, DM, downstate, ECI, encompassing, error, Exelon, FEJA, forfeiture, Hopewell, inhibiting, inquiry, intertwined, intrastate, IPAA, knowingly, MA, Marco, MassDEP, Megawatt, Midlothian, misleading, motivate, MUFG, NELP, Network, NextEra, NOAA, Norfolk, Northern, NY, Oceanic, officially, overfunded, PCAOB, PM, postponing, Postretirement, printing, promised, PSC, pursuit, quantifying, Railway, reconsider, reconsidered, recruiting, recruitment, refund, rejoining, repeal, repealed, repriced, repricing, requisite, reside, retiree, Rockland, sampling, segregated, Sierra, Sithe, smaller, sponsorship, Spruce, Stable, Starwood, subtotal, sue, suppressing, surrendered, suspension, taxation, TCJA, thirteenth, tonnage, unchecked, unsubordinated, UWUA, viii, Vistra, WIIN, Wise, withdrew, ZEC

Removed: adjacent, annum, appealed, appealing, appoint, arrangement, attempted, bear, beneficially, Black, boiler, cancelled, CCA, charter, choose, Cogeneration, combining, commencing, commitment, comparing, concurrent, convert, Council, CPUC, dealer, declined, DH, evident, expand, force, Fork, geotechnical, IGC, Illinova, indemnify, integrate, introduce, invalidated, IPM, Kendall, Kingston, Lender, localized, Mellon, Middle, mitigated, mixed, Morro, Mountain, offsite, optional, overturned, partiality, participant, partnership, Pine, pledging, Ponderosa, positioned, PPE, predecessor, preference, proceed, promissory, protest, recommend, recommended, recording, relation, relief, remained, removing, repeated, reversing, satisfaction, satisfactory, Secretary, sharing, soil, standby, strategic, Subtopic, successor, tenor, thousand, tranche, Transammonia, uprate, vacate, vacated, variance

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Dyne Therapeutics similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

(ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the report of Dynegy Inc. (the “Company”) on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert C. Flexon, President and Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for the purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:


(1)	the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and


(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.



Date:	February 22, 2018	By:	/s/ ROBERT C. FLEXON
			Robert C. Flexon President and Chief Executive Officer